Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionNon-benzodiazepine GABA A receptor modulator
Molecular Target GABA A receptor
Mechanism of ActionGABA A receptor modulator
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationSpeech disorder
Indication DetailsTreat persistent developmental stuttering; Treat stuttering
Regulatory Designation
PartnerTeva Pharmaceutical Industries Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today